Showing results (171-180 of 192) with videos related to

Sort By:
Pageof 20
Nature Immunology|May 30, 2017
The A946T variant of the RNA sensor IFIH1 mediates an interferon program that limits viral infection but increases the risk for autoimmunityJacquelyn A Gorman, Christian Hundhausen, John S Errett, et al.
Arthritis and Rheumatism|May 21, 2013
Performance of anti-cyclic citrullinated Peptide assays differs in subjects at increased risk of rheumatoid arthritis and subjects with established diseaseM Kristen Demoruelle, Mark C Parish, Lezlie A Derber, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|February 12, 2016
Associations of Smoking and Age With Inflammatory Joint Signs Among Unaffected First-Degree Relatives of Rheumatoid Arthritis Patients: Results From Studies of the Etiology of Rheumatoid ArthritisJeffrey A Sparks, Shun-Chiao Chang, Kevin D Deane, et al.
Annals of the Rheumatic Diseases|February 25, 2025
A coding single nucleotide polymorphism in the interleukin-6 receptor enhances IL-6 signalling in CD4 T cells and predicts treatment response to tocilizumab in giant cell arteritisRobert Zorc, Christopher Redmond, McKella Sylvester, et al.
Science Translational Medicine|October 26, 2022
Clonal IgA and IgG autoantibodies from individuals at risk for rheumatoid arthritis identify an arthritogenic strain of <i>Subdoligranulum</i>Meagan E Chriswell, Adam R Lefferts, Michael R Clay, et al.
Diabetes Care|September 14, 2023
Hydroxychloroquine in Stage 1 Type 1 DiabetesIngrid Libman, Polly J Bingley, Dorothy Becker, et al.
Journal of Medicinal Chemistry|August 6, 2008
Discovery and optimization of a novel series of N-arylamide oxadiazoles as potent, highly selective and orally bioavailable cannabinoid receptor 2 (CB2) agonistsYuan Cheng, Brian K Albrecht, James Brown, et al.
Biorxiv : the Preprint Server for Biology|November 24, 2025
Senescent Activated Naive B Cells Promote Anti-Citrullinated Antigen T Cell Responses and the Transition to Clinical Rheumatoid ArthritisXiaohao Wu, Mengrui Zhang, Jae-Seung Moon, et al.
JCI Insight|March 22, 2024
GNTI-122: an autologous antigen-specific engineered Treg cell therapy for type 1 diabetesGene I Uenishi, Marko Repic, Jennifer Y Yam, et al.
Iscience|June 11, 2021
Multimodal analysis for human <i>ex vivo</i> studies shows extensive molecular changes from delays in blood processingAdam K Savage, Miriam V Gutschow, Tony Chiang, et al.
Pageof 20